Simon Quick Advisors LLC Has $796,000 Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Simon Quick Advisors LLC boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 60.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,835 shares of the company's stock after buying an additional 1,818 shares during the period. Simon Quick Advisors LLC's holdings in Zoetis were worth $796,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new position in Zoetis in the fourth quarter valued at about $824,321,000. Wellington Management Group LLP increased its holdings in shares of Zoetis by 78.5% during the fourth quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company's stock worth $1,133,755,000 after buying an additional 3,059,255 shares in the last quarter. Sarasin & Partners LLP bought a new position in shares of Zoetis in the first quarter valued at approximately $339,111,000. GAMMA Investing LLC boosted its holdings in shares of Zoetis by 14,731.3% in the 1st quarter. GAMMA Investing LLC now owns 1,759,285 shares of the company's stock worth $289,666,000 after acquiring an additional 1,747,423 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in Zoetis during the 4th quarter worth approximately $196,651,000. Institutional investors own 92.80% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ZTS. Stifel Nicolaus cut their price objective on Zoetis from $180.00 to $165.00 and set a "buy" rating for the company in a research report on Monday, April 14th. UBS Group cut their price target on Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a report on Wednesday, May 7th. Piper Sandler upped their price target on shares of Zoetis from $205.00 to $210.00 and gave the stock an "overweight" rating in a research report on Monday, May 12th. Finally, Wall Street Zen upgraded shares of Zoetis from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. One investment analyst has rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $212.75.

Zoetis Trading Up 0.0%

ZTS stock traded up $0.03 during midday trading on Monday, reaching $164.36. The stock had a trading volume of 2,472,872 shares, compared to its average volume of 2,552,296. The firm has a market cap of $73.18 billion, a price-to-earnings ratio of 30.05, a PEG ratio of 2.78 and a beta of 0.94. Zoetis Inc. has a twelve month low of $139.70 and a twelve month high of $200.33. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09. The business has a fifty day simple moving average of $159.07 and a two-hundred day simple moving average of $163.75.

Zoetis (NYSE:ZTS - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.20 billion. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. The company's revenue for the quarter was up 1.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.38 EPS. As a group, research analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date of this dividend is Friday, July 18th. Zoetis's dividend payout ratio is presently 35.91%.

Insider Buying and Selling at Zoetis

In other news, EVP Roxanne Lagano sold 652 shares of the firm's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the transaction, the executive vice president now directly owns 15,129 shares in the company, valued at $2,571,930. This trade represents a 4.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.18% of the company's stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.